These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38736898)

  • 21. Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease.
    Gupta J; Fatima MT; Islam Z; Khan RH; Uversky VN; Salahuddin P
    Int J Biol Macromol; 2019 Jun; 130():515-526. PubMed ID: 30826404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the Pathological Hallmarks of Alzheimer's Disease Through Nanovesicleaided Drug Delivery Approach.
    Roy R; Bhattacharya P; Borah A
    Curr Drug Metab; 2022; 23(9):693-707. PubMed ID: 35619248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
    Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
    EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates.
    Barbara R; Belletti D; Pederzoli F; Masoni M; Keller J; Ballestrazzi A; Vandelli MA; Tosi G; Grabrucker AM
    Int J Pharm; 2017 Jun; 526(1-2):413-424. PubMed ID: 28495580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Interplay of Protein Aggregation, Genetics, and Oxidative Stress in Alzheimer's Disease: Role for Natural Antioxidants and Immunotherapeutics.
    Ali J; Choe K; Park JS; Park HY; Kang H; Park TJ; Kim MO
    Antioxidants (Basel); 2024 Jul; 13(7):. PubMed ID: 39061930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
    Cano A; Ettcheto M; Chang JH; Barroso E; Espina M; Kühne BA; Barenys M; Auladell C; Folch J; Souto EB; Camins A; Turowski P; García ML
    J Control Release; 2019 May; 301():62-75. PubMed ID: 30876953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
    Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
    Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer's disease.
    Sun D; Li N; Zhang W; Zhao Z; Mou Z; Huang D; Liu J; Wang W
    Colloids Surf B Biointerfaces; 2016 Dec; 148():116-129. PubMed ID: 27591943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
    Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
    Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer's Disease.
    Ma TJ; Gao J; Liu Y; Zhuang JH; Yin C; Li P; Mao L; Xu J; Xu YX; Li YP; Zhao ZX; Yin Y
    Mini Rev Med Chem; 2018; 18(12):1035-1046. PubMed ID: 29243575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious Update.
    Jan AT; Azam M; Rahman S; Almigeiti AMS; Choi DH; Lee EJ; Haq QMR; Choi I
    Front Aging Neurosci; 2017; 9():356. PubMed ID: 29163138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
    Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
    Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin-Pluronic Nanoparticles: A Theranostic Nanoformulation for Alzheimer's Disease.
    Singh A; Mahajan SD; Kutscher HL; Kim S; Prasad PN
    Crit Rev Biomed Eng; 2020; 48(3):153-168. PubMed ID: 33389893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease.
    Madav Y; Wairkar S; Prabhakar B
    Brain Res Bull; 2019 Mar; 146():171-184. PubMed ID: 30634016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Alzheimer's Disease: Beyond Symptomatic Therapies.
    Buccellato FR; D'Anca M; Tartaglia GM; Del Fabbro M; Scarpini E; Galimberti D
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer's Disease: Recent Trends and Future Development.
    Dave BP; Shah YB; Maheshwari KG; Mansuri KA; Prajapati BS; Postwala HI; Chorawala MR
    Cell Mol Neurobiol; 2023 Nov; 43(8):3847-3884. PubMed ID: 37725199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A sporadic Alzheimer's blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies.
    Wasielewska JM; Chaves JCS; Johnston RL; Milton LA; Hernández D; Chen L; Song J; Lee W; Leinenga G; Nisbet RM; Pébay A; Götz J; White AR; Oikari LE
    Theranostics; 2022; 12(16):6826-6847. PubMed ID: 36276649
    [No Abstract]   [Full Text] [Related]  

  • 40. A Synthetic Pro-Drug Peptide Reverses Amyloid-β-Induced Toxicity in the Rat Model of Alzheimer's Disease.
    Kumar S; Srivastav S; Fatima M; Giri RS; Mandal B; Mondal AC
    J Alzheimers Dis; 2019; 69(2):499-512. PubMed ID: 30958369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.